id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2014-E-0940-0007,FDA,FDA-2014-E-0940,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2018-11-23T05:00:00Z,2018,11,2018-11-23T05:00:00Z,,2018-11-23T16:06:32Z,,0,0,09000064838f607c
FDA-2014-E-0940-0006,FDA,FDA-2014-E-0940,"Determination of Regulatory Review Period for Purposes of Patent
Extension; LYMPHOSEEK",Notice,Determinations,2018-02-22T05:00:00Z,2018,2,2018-02-22T05:00:00Z,2018-04-24T03:59:59Z,2018-02-22T18:45:39Z,2018-03610,0,0,0900006482f51fe0